Broxol Expectorant

Introduction

Broxol is a medication that contains the active ingredient Ambroxol. It is available as a prescription medication and is used primarily as an expectorant.

Uses

Broxol is prescribed to help ease the symptoms associated with respiratory conditions that involve excessive mucus production, such as bronchitis, chronic obstructive pulmonary disease (COPD), and asthma. It helps to thin and loosen mucus in the airways, making it easier to cough up and clear the lungs.

Dosage and Administration

The dosage and administration instructions for Broxol may vary depending on individual factors and the severity of the condition being treated. Follow the instructions provided by your healthcare professional or the information on the product label.

Typically, the recommended dosage for adults and children over 12 years of age is 10 ml (2 teaspoons) of Broxol three times a day. For children aged 6 to 12 years, the recommended dosage is 5 ml (1 teaspoon) three times a day. The medication should be taken with water and can be taken with or without food.

Mechanism of Action

The active ingredient in Broxol, Ambroxol, works by increasing the production and clearance of mucus in the respiratory tract. It acts on the cells lining the airways, stimulating the production of a substance called surfactant. Surfactant helps to reduce the stickiness of mucus, making it easier to cough up and clear from the lungs.

Side Effects

Common side effects may include:

• Nausea
• Vomiting
• Indigestion
• Diarrhea
• Headache

If any of these side effects persist or become bothersome, consult your healthcare professional. Serious side effects are rare, but if you experience any signs of an allergic reaction, such as difficulty breathing, rash, or swelling of the face, lips, tongue, or throat, seek immediate medical attention.

Drug Interactions

There are currently no known significant drug interactions with Broxol. However, it is always important to inform your healthcare professional about all the medications you are taking, including prescription, over-the-counter, and herbal products, to ensure there are no potential interactions.

Precautions

Before using Broxol, inform your healthcare professional if you have any known allergies, especially to Ambroxol or any other ingredients in the medication. Disclose any other medical conditions you may have, as well as any other medications you are taking.

Broxol is generally considered safe for most individuals. However, it is not recommended for use in pregnant or breastfeeding women without consulting a healthcare professional.

Storage

Broxol should be stored in a cool, dry place, away from direct sunlight and moisture. Keep it out of reach of children and pets. Do not use the medication after the expiration date printed on the packaging.

Patient Tips

• Follow the dosage instructions provided by your healthcare professional or as indicated on the product label.
• Drink plenty of fluids to help thin and loosen mucus.
• If you miss a dose, take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
• If you have any concerns or questions about your treatment, do not hesitate to consult your healthcare professional.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Ambroxol (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• Malerba M, Ragnoli B. Ambroxol in the 21st century: pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008 Aug;4(8):1119-29. doi: 10.1517/17425255.4.8.1119. [Accessed 27 Jun. 2024] Available at:
• Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Ambroxol as a novel disease-modifying treatment for Parkinson’s disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. [Accessed 14 Jun. 2024] Available at:
• Weiser T. Ambroxol: a CNS drug? CNS Neurosci Ther. 2008 Spring;14(1):17-24. doi: 10.1111/j.1527-3458.2007.00032.x. [Accessed 19 Jun. 2024] Available at: